FibroGen Announces Roxadustat Inclusion in China’s National Reimbursement Drug List


You May Also Like

IASLC Invites Lung Cancer Professionals to Take Global Survey on Molecular Testing 

Global Leader in Thoracic Malignancies Conducting Survey to Assess & Improve Molecular Testing WorldwideDENVER, ...

Prima BioMed Announces Formation of Clinical Advisory Board

New Clinical Advisory Board comprises team of internationally renowned cliniciansProvides strategic advice for clinical ...